{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:58:03Z","timestamp":1783997883830,"version":"3.55.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hereditary heart disease (HHD) is a series of cardiac disorders associated with monogenic or polygenic abnormalities and is one of the leading causes of sudden death, particularly in young adults. The updated European Cardiology guideline for cardiomyopathies provides the first comprehensive summary of genotyping, imaging, and therapy recommendations for inherited cardiomyopathies, but still lacks a comprehensive discussion of research advances and future trends in genetic diagnosis and therapy of HHD. Our research aims to fill this gap. Bibliometric analysis software (CiteSpace 6.3.R1, VOSviewer 1.6.18, and Scimago Graphica) was used to analyze the general information, trends, and emerging foci of HHD in the past 20 years, including author, country, institution, keyword, and so on. There were 5,757 publications were screened and aggregated in the database, including 1876 reviews and 3,881 articles. Hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy (ACM), Brugada syndrome (BrS), myocardial amyloidosis, and Fabry disease (FD) were the main types of HHD that were explored in greater depth. Moreover, new diagnostic methods, clinical cohorts, and genetically targeted therapies for HHD patients are key research hotspots. The relationship between the pathogenicity of genes and prognosis will become increasingly important for therapy.<\/jats:p>","DOI":"10.3389\/fmed.2024.1507313","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:15:58Z","timestamp":1736316958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024"],"prefix":"10.3389","volume":"11","author":[{"given":"Huixi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lini","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00424-019-02257-4","article-title":"Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains","volume":"471","author":"Yadav","year":"2019","journal-title":"Pflugers Arch"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.hlc.2019.10.014","article-title":"Genetic testing in inherited heart diseases","volume":"29","author":"Ingles","year":"2020","journal-title":"Heart Lung Circ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/europace\/euaa065","article-title":"European heart rhythm association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population","volume":"22","author":"Nielsen","year":"2020","journal-title":"Europace"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacep.2022.12.008","article-title":"Management of ventricular arrhythmias worldwide: comparison of the latest ESC, AHA\/ACC\/HRS, and CCS\/CHRS guidelines","volume":"9","author":"K\u00f6nemann","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1161\/CIR.0000000000000631","article-title":"Genetic basis for congenital heart disease: revisited: a scientific statement from the American heart association","volume":"138","author":"Pierpont","year":"2018","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e000067","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American heart association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/CIRCULATIONAHA.116.024258","article-title":"Next-generation sequencing in cardiovascular disease: present clinical applications and the horizon of precision medicine","volume":"135","author":"Parikh","year":"2017","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jcmg.2020.03.003","article-title":"Cardiovascular imaging through the prism of modern metrics","volume":"13","author":"Choi","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1161\/CIR.0000000000001094","article-title":"Assessing the impact of the American heart association's research portfolio: a scientific statement from the American heart association","volume":"146","author":"Creager","year":"2022","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2022.10.023","article-title":"Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis","volume":"352","author":"Pei","year":"2022","journal-title":"J Control Release"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103297","DOI":"10.1016\/j.drudis.2022.05.023","article-title":"A global bibliometric and visualized analysis of bacteria-mediated cancer therapy","volume":"27","author":"Wang","year":"2022","journal-title":"Drug Discov Today"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/CIN.0000000000001028","article-title":"Hotspots and global trends of nursing research on telehealth from 2012 to 2021: A bibliometric analysis by CiteSpace","volume":"41","author":"Yang\u00f6z","year":"2023","journal-title":"Comput Inform Nurs"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"107887","DOI":"10.1016\/j.pec.2023.107887","article-title":"Prostate cancer, online health information and communication technology - bibliometric analysis of field with research frontiers","volume":"115","author":"Jackson","year":"2023","journal-title":"Patient Educ Couns"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"104979","DOI":"10.1016\/j.neubiorev.2022.104979","article-title":"Thirty years of research on negative symptoms of schizophrenia: a scientometric analysis of hotspots, bursts, and research trends","volume":"144","author":"Sabe","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref20","first-page":"2733","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume-title":"Eur Heart J","author":"Elliott","year":"2014"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/schbul\/sbab132","article-title":"Exploring the relationship between schizophrenia and cardiovascular disease: a genetic correlation and multivariable mendelian randomization study","volume":"48","author":"Veeneman","year":"2022","journal-title":"Schizophr Bull"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-a heart failure society of American practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00424-020-02486-y","article-title":"Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine","volume":"473","author":"Pan","year":"2021","journal-title":"Pflugers Arch"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3238\/arztebl.2011.0623","article-title":"Inherited cardiac arrhythmias: diagnosis, treatment, and prevention","volume":"108","author":"Beckmann","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/europace\/euac030","article-title":"European heart rhythm association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"24","author":"Wilde","year":"2022","journal-title":"Europace"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/s0735-1097(02)01900-9","article-title":"Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective","volume":"39","author":"Ackerman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1093\/eurheartj\/ehac145","article-title":"Importance of genetic testing in unexplained cardiac arrest","volume":"43","author":"Grondin","year":"2022","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13073-023-01221-3","article-title":"Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human","volume":"15","author":"Niskanen","year":"2023","journal-title":"Genome Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1161\/CIRCULATIONAHA.113.002252","article-title":"Genetic testing for inherited heart disease","volume":"128","author":"Cirino","year":"2013","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.mayocp.2017.01.015","article-title":"Precision cardiovascular medicine: state of genetic testing","volume":"92","author":"Giudicessi","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-023-39253-3","article-title":"Genome-wide association analysis and mendelian randomization proteomics identify drug targets for heart failure","volume":"14","author":"Rasooly","year":"2023","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"euad079","DOI":"10.1093\/europace\/euad079","article-title":"Genetic testing in children with brugada syndrome: results from a large prospective registry","volume":"25","author":"Pannone","year":"2023","journal-title":"Europace"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jamacardio.2022.2455","article-title":"Assessment of the diagnostic yield of combined cardiomyopathy and arrhythmia genetic testing","volume":"7","author":"Dellefave-Castillo","year":"2022","journal-title":"JAMA Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41436-021-01159-0","article-title":"Combining exome\/genome sequencing with data repository analysis reveals novel gene-disease associations for a wide range of genetic disorders","volume":"23","author":"Bertoli-Avella","year":"2021","journal-title":"Genet Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/europace\/euaa223","article-title":"Diagnosis, family screening, and treatment of inherited arrhythmogenic diseases in Europe: results of the European heart rhythm association survey","volume":"22","author":"Conte","year":"2020","journal-title":"Europace"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/CIRCULATIONAHA.117.030142","article-title":"Classification and reporting of potentially proarrhythmic common genetic variation in long QT syndrome genetic testing","volume":"137","author":"Giudicessi","year":"2018","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e0297914","DOI":"10.1371\/journal.pone.0297914","article-title":"The importance of variant reinterpretation in inherited cardiovascular diseases: establishing the optimal timeframe","volume":"19","author":"Fernandez-Falgueras","year":"2024","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41569-021-00555-y","article-title":"Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death","volume":"18","author":"Scrocco","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","article-title":"Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test","volume":"20","author":"Lionel","year":"2018","journal-title":"Genet Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3343\/alm.2018.38.4.291","article-title":"Principles of genetic counseling in the era of next-generation sequencing","volume":"38","author":"Yang","year":"2018","journal-title":"Ann Lab Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(18)31940-8","article-title":"Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study","volume":"393","author":"Lord","year":"2019","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am J Hum Genet"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.121.058143","article-title":"Frequency, penetrance, and variable expressivity of dilated cardiomyopathy-associated putative pathogenic gene variants in UK biobank participants","volume":"146","author":"Shah","year":"2022","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jacc.2023.02.038","article-title":"Familial hypercholesterolemia: challenges for a high-risk population: JACC focus seminar 1\/3","volume":"81","author":"Choi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European society of cardiology working group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20517\/jca.2021.15","article-title":"A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family","volume":"1","author":"Pourebrahim","year":"2021","journal-title":"J Cardiovasc Aging"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/humu.24436","article-title":"Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form-associated genes provides new insights for molecular diagnosis and clinical management","volume":"43","author":"Goudal","year":"2022","journal-title":"Hum Mutat"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.hrthm.2020.01.035","article-title":"Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5","volume":"17","author":"Dominguez","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1162205","DOI":"10.3389\/fcvm.2023.1162205","article-title":"Phospholamban R14del disease: the past, the present and the future","volume":"10","author":"Vafiadaki","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"8753","DOI":"10.3390\/ijms23158753","article-title":"Arrhythmogenic cardiomyopathy: exercise pitfalls, role of connexin-43, and moving beyond antiarrhythmics","volume":"23","author":"Coscarella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"16A","DOI":"10.1016\/s0828-282x(07)71001-2","article-title":"Electrical heart disease: genetic and molecular basis of cardiac arrhythmias in normal structural hearts","volume":"23","author":"Farwell","year":"2007","journal-title":"Can J Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000938","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: A report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddab249","article-title":"A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank","volume":"31","author":"Park","year":"2022","journal-title":"Hum Mol Genet"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41591-022-02184-5","article-title":"CRISPR gene-editing therapies for hypertrophic cardiomyopathy","volume":"29","author":"Strong","year":"2023","journal-title":"Nat Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/eurheartj\/ehab424","article-title":"Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy","volume":"42","author":"Lopes","year":"2021","journal-title":"Eur Heart J"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ejhf.2414","article-title":"Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the heart failure association (HFA) and the working group on myocardial function of the European Society of Cardiology (ESC)","volume":"24","author":"de Boer","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/biom9120878","article-title":"Hypertrophic cardiomyopathy: an overview of Genetics and management","volume":"9","author":"Teekakirikul","year":"2019","journal-title":"Biomol Ther"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy","volume":"78","author":"de Marvao","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","article-title":"Genome-wide association analyses identify new brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility","volume":"54","author":"Barc","year":"2022","journal-title":"Nat Genet"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/eurheartj\/ehaa942","article-title":"Brugada syndrome genetics is associated with phenotype severity","volume":"42","author":"Ciconte","year":"2021","journal-title":"Eur Heart J"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41569-022-00744-3","article-title":"Gene therapy for Brugada syndrome","volume":"19","author":"Huynh","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"102843","DOI":"10.1016\/j.ebiom.2020.102843","article-title":"GSTM3 variant is a novel genetic modifier in brugada syndrome, a disease with risk of sudden cardiac death","volume":"57","author":"Juang","year":"2020","journal-title":"EBioMedicine"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.hrthm.2022.01.034","article-title":"SCN5A mutation in brugada syndrome is associated with substrate severity detected by electrocardiographic imaging and high-density electroanatomic mapping","volume":"19","author":"Pannone","year":"2022","journal-title":"Heart Rhythm"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/heartjnl-2021-320015","article-title":"Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death","volume":"109","author":"Specterman","year":"2023","journal-title":"Heart"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.123.064673","article-title":"Treatment of brugada syndrome in 2023: know where you come from to know where you are going","volume":"147","author":"Viskin","year":"2023","journal-title":"Circulation"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: A report of the American college of cardiology solution set oversight committee","volume":"81","author":"Committee","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J Intern Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14797\/mdcvj.1050","article-title":"Cardiac amyloidosis treatment","volume":"18","author":"Stern","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/gim.2017.175","article-title":"Low frequency of fabry disease in patients with common heart disease","volume":"20","author":"Schiffmann","year":"2018","journal-title":"Genet Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/genes15010037","article-title":"Fabry disease in women: genetic basis, available biomarkers, and clinical manifestations","volume":"15","author":"Izhar","year":"2023","journal-title":"Genes"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cells13050437","article-title":"GLA mutations suppress autophagy and stimulate lysosome generation in fabry disease","volume":"13","author":"Li","year":"2024","journal-title":"Cells"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"e14297","DOI":"10.15252\/emmm.202114297","article-title":"Autologous, lentivirus-modified, T-rapa cell \"micropharmacies\" for lysosomal storage disorders","volume":"14","author":"Nagree","year":"2022","journal-title":"EMBO Mol Med"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2174\/1570159X20666220601124117","article-title":"Fabry disease: current and novel therapeutic strategies","volume":"21","author":"Palaiodimou","year":"2023","journal-title":"Narrat Rev Curr Neuropharmacol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/cdt-20-593","article-title":"Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations","volume":"11","author":"Linhart","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ekir.2019.11.013","article-title":"Current and investigational therapeutics for fabry disease","volume":"5","author":"Felis","year":"2019","journal-title":"Kidney Int Rep"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","article-title":"Fabry disease: the current treatment landscape","volume":"81","author":"Lenders","year":"2021","journal-title":"Drugs"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","article-title":"Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy","volume":"2","author":"Kyriakopoulou","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.omtm.2020.07.002","article-title":"AAV2\/6 gene therapy in a murine model of Fabry disease results in Supraphysiological enzyme activity and effective substrate reduction","volume":"18","author":"Yasuda","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.ymgme.2024.108545","article-title":"Restoration of peripheral neuropathy in Fabry mice via intrathecal administration of an adeno-associated virus vector encoding mGLA cDNA","volume":"143","author":"Higuchi","year":"2024","journal-title":"Mol Genet Metab"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1507313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:16:04Z","timestamp":1736316964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1507313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":95,"alternative-id":["10.3389\/fmed.2024.1507313"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1507313","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"article-number":"1507313"}}